Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M420Revenue (TTM) $M36.6Net Margin (%)1.4Altman Z-Score30.1
Enterprise Value $M310EPS (TTM) $--Operating Margin %-0.5Piotroski F-Score5
P/E(ttm)--Beneish M-Score24.2Pre-tax Margin (%)1.4Higher ROA y-yY
Price/Book3.110-y EBITDA Growth Rate %--Quick Ratio16.7Cash flow > EarningsN
Price/Sales11.75-y EBITDA Growth Rate %--Current Ratio16.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)0.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)0.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M159ROIC % (ttm)-2.1Gross Margin Increase y-yN

Gurus Latest Trades with GERN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GERNJoel Greenblatt 2016-03-31 Add0.01%$2.41 - $4.84
($3.02)
$ 2.64-13%Add 55.63%466,859
GERNJoel Greenblatt 2015-12-31 Buy 0.02%$2.91 - $5.12
($4.06)
$ 2.64-35%New holding299,986
GERNFirst Eagle Investment 2015-12-31 Reduce$2.91 - $5.12
($4.06)
$ 2.64-35%Reduce -3.04%159,700
GERNFirst Eagle Investment 2015-06-30 Reduce-0.01%$3.62 - $4.33
($3.96)
$ 2.64-33%Reduce -77.40%164,700
GERNFirst Eagle Investment 2015-03-31 Reduce$2.81 - $4.34
($3.39)
$ 2.64-22%Reduce -35.43%728,866
GERNFirst Eagle Investment 2014-12-31 Reduce-0.01%$1.85 - $3.84
($2.78)
$ 2.64-5%Reduce -48.64%1,128,866
GERNFirst Eagle Investment 2014-09-30 Reduce-0.01%$2.12 - $3.014
($2.46)
$ 2.647%Reduce -38.05%2,198,124
GERNFirst Eagle Investment 2014-03-31 Add0.01%$1.6 - $5.4
($4.04)
$ 2.64-35%Add 46.43%3,054,252
GERNFirst Eagle Investment 2013-03-31 Add$1.01 - $1.64
($1.38)
$ 2.6491%Add 36.91%2,410,934
GERNGeorge Soros 2011-03-31 Sold Out $4.44 - $5.07
($4.71)
$ 2.64-44%Sold Out0
GERNFirst Eagle Investment 2010-12-31 Add0.03%$4.46 - $6.02
($5.23)
$ 2.64-50%Add 74.80%2,570,500
GERNGeorge Soros 2010-12-31 Buy $4.46 - $6.02
($5.23)
$ 2.64-50%New holding26,500
GERNFirst Eagle Investment 2010-06-30 Add0.02%$4.67 - $5.81
($5.13)
$ 2.64-49%Add 77.56%1,420,500
GERNFirst Eagle Investment 2010-03-31 Add0.03%$4.97 - $6.21
($5.58)
$ 2.64-53%Add 204.80%800,000
GERNFirst Eagle Investment 2009-12-31 Add0.02%$4.91 - $6.69
($5.55)
$ 2.64-52%Add 556.18%262,471
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GERN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GERN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BEHRS MELISSA KELLYEVP BD and Port&Alliance Mgmt 2015-05-29Sell2,380$3.84-31.25view
Bloom Olivia KyusukEVP, CFO 2015-05-29Sell2,380$3.84-31.25view
Hofstaetter ThomasDirector 2015-03-18Sell70,000$4.1-35.61view
Bloom Olivia KyusukEVP, CFO 2014-05-29Sell3,379$2.125.71view
BEHRS MELISSA KELLYEVP Portfolio & Alliance Mgmt 2014-05-29Sell4,826$2.125.71view
BRADBURY DANIELDirector 2014-05-09Buy142,776$1.7550.86view
BEHRS MELISSA KELLYEVP Portfolio & Alliance Mgmt 2014-04-01Sell12,310$2.1323.94view
Bloom Olivia KyusukEVP, CFO 2014-04-01Sell7,435$2.1323.94view
SCARLETT JOHN APresident and CEO 2013-04-01Buy50,000$1.03156.31view
BEHRS MELISSA KELLYSVP Alliance and Prog Mgmt 2013-01-17Sell28,292$1.6560view

Quarterly/Annual Reports about GERN:

News about GERN:

Articles On GuruFocus.com
Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU Apr 07 2013 
WEEKLY CFO SELLS HIGHLIGHT: HTM, OVTI, VSEA, KSWS,GERN, ATRC Jun 20 2011 
Geron Corp. Reports Operating Results (10-Q) Oct 29 2010 
Geron: Buyer Beware Oct 13 2010 
Geron Corp. (GERN) President and CEO Thomas Okarma sells 18,874 Shares Jun 03 2010 
Geron Corp. (GERN) EVP and CFO David Greenwood sells 14,746 Shares Jun 03 2010 
Banking 60% on the Day the World Changed: FDA Approves Geron to Test Embryonic Stem Cells on Humans Jan 24 2009 
The Next Boom Emerges Nov 23 2008 

More From Other Websites
GERON CORP Files SEC form 8-K, Other Events Jul 25 2016
ETF’s with exposure to Geron Corp. : July 20, 2016 Jul 20 2016
Biotech Equities Technical Briefing on Array BioPharma, Geron, Emergent BioSolutions, and Global... Jul 18 2016
Geron (GERN) Gets Three Patents for Imetelstat in the U.S. Jul 14 2016
Geron Announces Issuance of U.S. Patents Related to Imetelstat Jul 13 2016
Geron Announces Issuance of U.S. Patents Related to Imetelstat Jul 13 2016
ETF’s with exposure to Geron Corp. : June 20, 2016 Jun 20 2016
ETF’s with exposure to Geron Corp. : June 6, 2016 Jun 06 2016
Geron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : June 2, 2016 Jun 02 2016
GERON CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 19 2016
ETF’s with exposure to Geron Corp. : May 19, 2016 May 18 2016
Geron Corp. :GERN-US: Earnings Analysis: Q1, 2016 By the Numbers May 16 2016
GERON CORP Financials May 13 2016
Actinium Pharmaceuticals Remains Significantly Undervalued May 10 2016
Can Geron Shares Still Ultimately Double? May 08 2016
Edited Transcript of GERN earnings conference call or presentation 5-May-16 8:30pm GMT May 06 2016
Geron (GERN) Q1 Loss In-Line, Imetelstat Remains in Focus May 06 2016
ETF’s with exposure to Geron Corp. : May 5, 2016 May 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)